The plasminogen activator urokinase and its inhibitor PAI-2 in endometrial cancer
- 31 October 1992
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 47 (1), 58-61
- https://doi.org/10.1016/0090-8258(92)90076-u
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignanciesEuropean Journal of Clinical Investigation, 2008
- The concentration of tissue plasminogen activator and urokinase in plasma and tissues of patients with ovarian and uterine tumorsThrombosis Research, 1990
- Interleukin-1, endotoxin or tumor necrosis factor/cachectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cellsThrombosis Research, 1989
- Isolation of a new specific plasminogen activator in hibitor from pregnancy plasmaBritish Journal of Haematology, 1986
- Differential inhibition of two molecular forms of melanoma cell plasminogen activator by a placental inhibitorBritish Journal of Haematology, 1984
- Plasminogen activator and cancerEuropean Journal of Cancer and Clinical Oncology, 1984
- Antibodies to plasminogen activator inhibit human tumor metastasisCell, 1983
- Improved Medium for Extraction of Plasminogen Activator from TissuePreparative Biochemistry, 1982
- An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue cultureBiochimica et Biophysica Acta (BBA) - General Subjects, 1978
- Urokinase Inhibitor in Human PlacentaNature, 1967